Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
analysts
CRO
CROs should brace for continued slow Big Pharma demand: analyst
While large pharma spending on R&D increased by 9.7% in 2024, it's expected to increase by only 2.2% this year for 13 Big Pharmas.
Darren Incorvaia
Jan 28, 2025 3:45pm
CRO and clinical trial markets set for growth by 2030: reports
Dec 4, 2024 3:15pm
In first, autoimmune patients respond to allogeneic CAR-T cells
Jul 17, 2024 3:26pm
Sanofi tries to quiet naysayers with data on Principia MS drug
Oct 14, 2021 10:05am
Pfizer stumbles close to finish line in growth hormone race
Sep 27, 2021 7:05am
Pfizer deal a spark for M&A, or fuel for an empty pipeline?
Aug 24, 2021 9:32am
